Aveanna director Samuel Altman files Form 3

Aveanna Healthcare Holdings, Inc. director Samuel Altman has filed an initial Form 3 statement of beneficial ownership.

Accepted by SEC EDGAR 03/18/2026 - 05:30 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Aveanna Healthcare Holdings, Inc. director Samuel Altman has filed an initial Form 3 statement of beneficial ownership. The excerpt lists him as a director of the company and shows no reported buy, sell, or other share transactions in this filing data.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Aveanna Healthcare (AVAH) disclose in Samuel Altman’s Form 3?

The filing identifies Samuel Altman as a director of Aveanna Healthcare Holdings, Inc. It shows no reported purchases, sales, or other share transactions in the provided Form 3 data.

Does Samuel Altman report any stock transactions in this AVAH Form 3?

No, the summarized data for this Form 3 shows zero buy, sell, acquire, or dispose transactions and no derivative exercises or gifts associated with Samuel Altman.

What insider role does Samuel Altman hold at Aveanna Healthcare (AVAH)?

Samuel Altman is listed as a director of Aveanna Healthcare Holdings, Inc. in this Form 3. He is not flagged as an officer or ten‑percent owner in the provided data.

Are there any derivative securities reported for Samuel Altman on AVAH’s Form 3?

No, the derivative summary in the filing is empty, and the transaction summary shows zero derivative transactions, indicating no listed options or similar instruments in this excerpt.

What does the transaction summary indicate in this AVAH Form 3?

The transaction summary reports zero buys, sells, exercises, gifts, or tax‑withholding events, and a net buy/sell direction labeled neutral for Samuel Altman in this Form 3 data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Weil Samuel Altman

(Last) (First) (Middle)

C/O BAIN CAPITAL INVESTORS, LLC

200 CLARENDON STREET

(Street)

BOSTON MASSACHUSETTS 02116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
11/13/2025

3. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Samuel Weil	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)